{"id":"NCT00289887","sponsor":"Organon and Co","briefTitle":"Obese Hypertension Study (0954-315)","officialTitle":"A Double-Blind, Randomized, Parallel, Efficacy Study Evaluating Losartan Potassium Alone or in Combination With Hydrochlorothiazide Versus Placebo in Obese Patients With Elevated Systolic and Diastolic Blood Pressure","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2007-02","completion":"2007-03","firstPosted":"2006-02-10","resultsPosted":"2010-05-27","lastUpdate":"2022-02-09"},"enrollment":261,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Comparator: losartan +/- HCTZ","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"This is a 16-week study to evaluate high systolic and diastolic blood pressure following treatment in obese, hypertensive, adult patients.","primaryOutcome":{"measure":"Mean Change From Baseline in Trough Sitting Systolic Blood Pressure (SiSBP) at Week 8","timeFrame":"At baseline and at 8 weeks (with the measurements taken prior to the morning dose, between 6 AM and 10 AM)","effectByArm":[{"arm":"Losartan","deltaMin":-12.1,"sd":1.2},{"arm":"Placebo","deltaMin":-6.8,"sd":1.2}],"pValues":[]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["18328120"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":127},"commonTop":["Headache"]}}